JABET Explore more articles

Table 3. Comparison between VDRL and TPHA titers in syphilis patients with and without HIV.

Syphilis

VDRL

TPHA

HIV (+)

HIV (-)

HIV (+)

HIV (-)

Baseline

Mean ± SD

1:151 ± 1:379

1:23 ± 1:32

1:13,254 ± 1:15,810

1:2,993 ± 1:4,287

Median (range)

1:64

(1:2-1:2,048)

1:16

(1:2-1:128)

1:5,120

(1:320-1:40,960)

1:2,560

(1:80-1:20,480)

p-value

0.001

0.002

1 Month Follow-Up After Therapy

Mean ± SD

1:45 ± 1:44

1:11 ± 1:14

1:6,562 ± 1:10,739

1:3,260 ± 1:5,291

Median (range)

1:32

(1:2-1:128)

1:4

(0-1:64)

1:2,560

(1:128-1:40,960)

1:1280

(0-1:20,480)

p-value

0.001

0.082

Last Follow-Up After Therapy

Mean ± SD

1:45 ± 1:44

1:11 ± 1:14

1:6,562 ± 1:10,739

1:3,260 ± 1:5,291

Median (range)

1:32

(1:2-1:128)

1:4

(0-1:64)

1:2,560

(1:128-1:40,960)

1:1280

(0-1:20,480)

p-value

0.001

0.018